Treatment duration with Curderm varies based on several factors, including lesion size, thickness, location, and how long the abnormal cells have been present. Most early-stage non-melanoma skin cancers respond within four to eight weeks.
Smaller, superficial lesions may show visible improvement within two to three weeks. Larger or deeper lesions often require longer treatment as the skin cancer cream works through successive layers of abnormal tissue.
Inflammation typically increases before improvement becomes obvious. This phase reflects active cell destruction rather than treatment failure. Visual worsening during early stages is expected.
Once active treatment ends, healing continues for several weeks. Redness and pinkness gradually fade as new skin strengthens and collagen remodelling occurs. Final cosmetic appearance may continue improving for months.
Patience is essential. Stopping treatment prematurely increases the risk of recurrence. Completing the full course ensures deeper abnormal cells are addressed.
Curderm is often chosen by patients who prefer gradual treatment over surgical intervention. Understanding the timeline helps users remain committed through the inflammatory stages and avoid unnecessary concern.